CCL28 and Alzheimer disease: We found that GCA+ immune cells specifically expressed high levels of CCR10, a receptor for CCL28, which is involved in immune and inflammatory regulation in various diseases, such as tumors,[30] spinal cord injury,[31] and skin diseases.[32] However, there are currently no studies confirming the role of the CCR10‐CCL28 axis in AD.